問卷

TPIDB > Principal Investigator

Principal Investigator


China Medical University Hospital (在職)

Division of General Internal Medicine

Division of Rheumatology

更新時間:2023-09-19

張詩欣
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

33Cases

2016-03-08 - 2017-10-05

Others

A PHASE 3, MULTICENTER, LONG-TERM OBSERVATIONAL STUDY OF SUBJECTS FROM TANEZUMAB STUDIES WHO UNDERGO A TOTAL KNEE, HIP OR SHOULDER REPLACEMENT
  • Condition/Disease

    chronic pain and acute pain

  • Test Drug

    Tanezumab (PF-04383119 )

Participate Sites
6Sites

Terminated5Sites

2021-03-01 - 2024-12-10

Phase I

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

1 2 3 4